Table 1 Clinical data for Meige syndrome patients and control subjects.
From: Grey matter changes in Meige syndrome: a voxel-based morphology analysis
Patients | Controls | P value | |
|---|---|---|---|
Gender (female) | 35 | 39 | 0.104 |
Age (years) | 57.00 ± 8.86 | 52.71 ± 6.26 | 0.083 |
BFMDRS movement scores | 7.87 ± 2.45 | 0.43 ± 0.49 | 0.000 |
HAMD scores | 16.96 ± 4.84 | 5.51 ± 2.95 | 0.000 |
Disease duration (years) | 4.57 ± 2.23 | – | – |
Distribution (n) | – | – | |
Blepharospasm | 18 | – | – |
Oromandibular dystonia | 5 | – | – |
Both | 23 | – | – |
Total | 46 | 64 | – |
